About Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica
Clinical Trials at Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica
During the past decade, Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica"
#1 collaborator was "Clirest s.r.l." with 2 trials as a collaborator, "Temas srl" with 2 trials as a collaborator, "Arithmos srl" with 1 trials as a collaborator, "Clinical Research Technology S.r.l." with 1 trials as a collaborator and "Clinical research technology Srl" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica
According to Clinical.Site data, the most researched conditions in "Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica" are
"Carcinoma, Non-Small-Cell Lung" (2 trials), "Cancer, Breast" (1 trials), "Small Cell Lung Cancer" (1 trials) and "Squamous-Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica" in a lesser frequency.
Clinical Trials Intervention Types at Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica
Most popular intervention types in "Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Crizotinib" (1 trials), "Docetaxel" (1 trials), "Lorlatinib" (1 trials), "Nabpaclitaxel" (1 trials) and "Nivolumab plus Ipilimumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica
The vast majority of trials in "Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica" are
5 trials for "All" genders.
Clinical Trials Status at Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica
Currently, there are NaN active trials in "Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sacro Cuore- Don Calabria Hospital- U.O.C. Oncologia Medica, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".